NCT05321355 Mainz Register of Patients With Sleep Disorders
| NCT ID | NCT05321355 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johannes Gutenberg University Mainz |
| Condition | Sleep Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2030-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-02-01 with a primary completion date of 2030-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective longitudinal observational registry study of all patients with sleep disorders treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.
Eligibility Criteria
Inclusion Criteria: * patients with narcolepsy * patients with other neurological sleep disorders Exclusion Criteria: * patients aged \<18 years * patients who cannot provide informed consent and don't have a legal guardian
Frequently Asked Questions
Who can join the NCT05321355 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Sleep Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05321355 currently recruiting?
Yes, NCT05321355 is actively recruiting participants. Visit ClinicalTrials.gov or contact Johannes Gutenberg University Mainz to inquire about joining.
Where is the NCT05321355 trial being conducted?
This trial is being conducted at Mainz, Germany.
Who is sponsoring the NCT05321355 clinical trial?
NCT05321355 is sponsored by Johannes Gutenberg University Mainz. The trial plans to enroll 500 participants.